Archives
|
Entry
|
Blogger
|
Date
▴
|
Location
|
|
Curis Gets $3M From Genentech For Ovarian Cancer Trial Initiation
|
Luke Timmerman |
12/08/08 |
Boston
|
|
Hold on Tight: Biotech Execs Predict Hard Times for Industry as Cash Dwindles
|
Luke Timmerman |
11/25/08 |
National
|
|
Biotech Survival Index: Boston Life Sciences Companies Brace for Long, Hard Winter
|
Luke Timmerman |
11/25/08 |
Boston
|
|
Curis Begins Phase 1 Trial of Anti-Tumor Drug
|
Ryan McBride |
08/26/08 |
Boston
|
|
Concert Strikes a Chord With Investors, Abiomed Scores a Win with Medicare, Epix Snags $7.5M from GSK, & More Life Sciences News
|
Rebecca Zacks |
05/07/08 |
Boston
|
|
Let the Epic Curing Begin: Epix and Curis Earn Milestone Payments
|
Erik Mellgren |
05/05/08 |
Boston
|
|
Exact Sciences Makes the List, Curis and Alkermes Get Dropped, Patent Reform Sparks Debate, & More Life Sciences News
|
Rebecca Zacks |
03/12/08 |
Boston
|
|
Curis, Alkermes Down on News of Failed Pharma Partnerships
|
Rebecca Zacks |
03/10/08 |
Boston
|
|
Cleaning the Slate, Raising Funds, and Filling the Executive Suite
|
Rebecca Zacks |
08/13/07 |
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2008 Xconomy. All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
